BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1552500)

  • 21. Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity.
    dos Santos Edos A; Hamel E; Bai R; Burnett JC; Tozatti CS; Bogo D; Perdomo RT; Antunes AM; Marques MM; Matos Mde F; de Lima DP
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4669-73. PubMed ID: 23810282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor agents. 174. 2',3',4',5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
    Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
    J Med Chem; 1997 Jul; 40(14):2266-75. PubMed ID: 9216846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A.
    Mu F; Hamel E; Lee DJ; Pryor DE; Cushman M
    J Med Chem; 2003 Apr; 46(9):1670-82. PubMed ID: 12699385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents.
    Zheng S; Zhong Q; Mottamal M; Zhang Q; Zhang C; Lemelle E; McFerrin H; Wang G
    J Med Chem; 2014 Apr; 57(8):3369-81. PubMed ID: 24669888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
    ter Haar E; Rosenkranz HS; Hamel E; Day BW
    Bioorg Med Chem; 1996 Oct; 4(10):1659-71. PubMed ID: 8931935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morpholino derivatives of benzyl-benzodioxole, a study of structural requirements for drug interactions at the colchicine/podophyllotoxin binding site of tubulin.
    Batra JK; Jurd L; Hamel E
    Biochem Pharmacol; 1986 Nov; 35(22):4013-8. PubMed ID: 3778522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
    Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
    Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization.
    Gastpar R; Goldbrunner M; Marko D; von Angerer E
    J Med Chem; 1998 Dec; 41(25):4965-72. PubMed ID: 9836614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imidazolone-amide bridges and their effects on tubulin polymerization in cis-locked vinylogous combretastatin-A4 analogues: synthesis and biological evaluation.
    Li YW; Liu J; Liu N; Shi D; Zhou XT; Lv JG; Zhu J; Zheng CH; Zhou YJ
    Bioorg Med Chem; 2011 Jun; 19(11):3579-84. PubMed ID: 21536450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents.
    Kamal A; Bajee S; Lakshma Nayak V; Venkata Subba Rao A; Nagaraju B; Ratna Reddy C; Jeevak Sopanrao K; Alarifi A
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2957-2964. PubMed ID: 27161282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.
    Pettit GR; Singh SB; Hamel E; Lin CM; Alberts DS; Garcia-Kendall D
    Experientia; 1989 Feb; 45(2):209-11. PubMed ID: 2920809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para-nitrogen substituted isocombretastatins.
    Jiménez C; Ellahioui Y; Álvarez R; Aramburu L; Riesco A; González M; Vicente A; Dahdouh A; Ibn Mansour A; Jiménez C; Martín D; Sarmiento RG; Medarde M; Caballero E; Peláez R
    Eur J Med Chem; 2015 Jul; 100():210-22. PubMed ID: 26092446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diaryl disulfides and thiosulfonates as combretastatin A-4 analogues: Synthesis, cytotoxicity and antitubulin activity.
    Khodyuk RGD; Bai R; Hamel E; Lourenço EMG; Barbosa EG; Beatriz A; Dos Santos EDA; de Lima DP
    Bioorg Chem; 2020 Aug; 101():104017. PubMed ID: 32629276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin.
    Lin CM; Ho HH; Pettit GR; Hamel E
    Biochemistry; 1989 Aug; 28(17):6984-91. PubMed ID: 2819042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological studies of novel tubulin inhibitors.
    Sun Y; Pandit B; Chettiar SN; Etter JP; Lewis A; Johnsamuel J; Li PK
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4465-8. PubMed ID: 23790539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4.
    Flynn BL; Flynn GP; Hamel E; Jung MK
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2341-3. PubMed ID: 11527727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
    Medarde M; Maya AB; Pérez-Melero C
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):521-40. PubMed ID: 15662956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel class of trans-methylpyrazoline analogs of combretastatins: synthesis and in-vitro biological testing.
    Lee M; Brockway O; Dandavati A; Tzou S; Sjoholm R; Satam V; Westbrook C; Mooberry SL; Zeller M; Babu B; Lee M
    Eur J Med Chem; 2011 Jul; 46(7):3099-104. PubMed ID: 21524832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel combretastatin analogues endowed with antitumor activity.
    Simoni D; Romagnoli R; Baruchello R; Rondanin R; Rizzi M; Pavani MG; Alloatti D; Giannini G; Marcellini M; Riccioni T; Castorina M; Guglielmi MB; Bucci F; Carminati P; Pisano C
    J Med Chem; 2006 Jun; 49(11):3143-52. PubMed ID: 16722633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.